Di Giulio, S.; Falcidia, C.; Foggi, G.; Bianco, M.; Gargiulo, L.; Valenti, M.; Costanzo, A.; Narcisi, A.; Ibba, L.
Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter Study. J. Clin. Med. 2025, 14, 6371.
https://doi.org/10.3390/jcm14186371
AMA Style
Di Giulio S, Falcidia C, Foggi G, Bianco M, Gargiulo L, Valenti M, Costanzo A, Narcisi A, Ibba L.
Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter Study. Journal of Clinical Medicine. 2025; 14(18):6371.
https://doi.org/10.3390/jcm14186371
Chicago/Turabian Style
Di Giulio, Sara, Costanza Falcidia, Giulio Foggi, Matteo Bianco, Luigi Gargiulo, Mario Valenti, Antonio Costanzo, Alessandra Narcisi, and Luciano Ibba.
2025. "Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter Study" Journal of Clinical Medicine 14, no. 18: 6371.
https://doi.org/10.3390/jcm14186371
APA Style
Di Giulio, S., Falcidia, C., Foggi, G., Bianco, M., Gargiulo, L., Valenti, M., Costanzo, A., Narcisi, A., & Ibba, L.
(2025). Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter Study. Journal of Clinical Medicine, 14(18), 6371.
https://doi.org/10.3390/jcm14186371
